|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03320 CHINARES PHARMA
Nominal 
5.330 +0.360 (+7.243%) Ranking Overview
Ranking based on 4 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
4
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 64.00 RMB (cts) | |
| Net Profit | 4,045.47 RMB (MIL) | DPS | 19.40 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 4,356.00 | 69.41 | 18.90 | -- | 4,522.00 | 4,257.17 |
| 2027 | 4,705.59 | 74.92 | 20.88 | -- | 5,053.00 | 4,497.00 |
| 2028 | 5,176.00 | 82.30 | 22.70 | -- | 5,567.00 | 4,785.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 4,449.00 | 70.81 | -- | NOMURA | Buy | 7.52 | 26/03/2026 | |
| 2026 | 4,263.00 | 68.00 | 20.00 | UBS | Buy | 6.90 | 25/03/2026 | |
| 2026 | 4,257.17 | 68.00 | 19.60 | MORGAN STANLEY | Overweight | 6.80 | 14/10/2025 | |
| 2026 | 4,522.00 | 72.00 | 18.20 | BANK OF AMERICA | Buy | 5.90 | 25/03/2026 | |
| 2027 | 4,764.00 | 75.83 | -- | NOMURA | -- | -- | 26/03/2026 | |
| 2027 | 4,497.00 | 72.00 | 22.00 | UBS | -- | -- | 25/03/2026 | |
| 2027 | 4,647.18 | 74.00 | 21.35 | MORGAN STANLEY | -- | -- | 14/10/2025 | |
| 2027 | 5,053.00 | 80.40 | 20.40 | BANK OF AMERICA | -- | -- | 25/03/2026 | |
| 2028 | 4,785.00 | 76.00 | 23.00 | UBS | -- | -- | 25/03/2026 | |
| 2028 | 5,567.00 | 88.60 | 22.40 | BANK OF AMERICA | -- | -- | 25/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 26/03/2026 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,045,468 |
| %Change | 20.729% |
| EPS / (LPS) | RMB 0.640 |
| NBV Per Share (¥) | RMB 8.183 |